Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease

The Bio Report - A podcast by Levine Media Group - Wednesdays

Categories:

Business

David Bearss, president and CEO of Halia Therapeutics, discusses the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for its therapeutic approach.